COMMUNIQUÉ DE PRESSE publié le 28/12/2023 à 14:10, il y a 2 années 3 mois NeoGenomics to Appeal Ruling NeoGenomics, Inc., a leading oncology testing services company, has announced that its subsidiary, NeoGenomics Laboratories, Inc., will appeal the preliminary injunction issued by the United States District Court for the Middle District of North Carolina. The court's ruling stated that Natera, Inc. has demonstrated a likelihood that products using RaDaR technology infringe one of its patents. However, the order allows patients already using RaDaR to continue their use and permits ongoing research projects, studies,
COMMUNIQUÉ DE PRESSE publié le 05/12/2023 à 14:00, il y a 2 années 3 mois NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response NeoGenomics, Inc. to present new data at San Antonio Breast Cancer Symposium highlighting utility of RaDaR for therapy response. The data includes an updated analysis of the TRACER study and the announcement of receipt of the first samples from the SURVIVE clinical trial NeoGenomics RaDaR Assay San Antonio Breast Cancer Symposium TRACER Study SURVIVE Clinical Trial
COMMUNIQUÉ DE PRESSE publié le 14/11/2023 à 13:00, il y a 2 années 4 mois NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
COMMUNIQUÉ DE PRESSE publié le 06/11/2023 à 22:05, il y a 2 années 4 mois NeoGenomics Reports Third Quarter 2023 Results
COMMUNIQUÉ DE PRESSE publié le 24/10/2023 à 13:00, il y a 2 années 5 mois NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
COMMUNIQUÉ DE PRESSE publié le 17/10/2023 à 15:20, il y a 2 années 5 mois NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023
Publié le 03/04/2026 à 18:46, il y a 1 jour 10 heures Disclosure of Share Capital and Voting Rights as of March 31, 2026
Publié le 03/04/2026 à 18:46, il y a 1 jour 10 heures Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Publié le 03/04/2026 à 18:01, il y a 1 jour 10 heures ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 03/04/2026 à 18:00, il y a 1 jour 11 heures ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 03/04/2026 à 18:00, il y a 1 jour 11 heures LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026
Publié le 02/04/2026 à 22:00, il y a 2 jours 7 heures Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Publié le 02/04/2026 à 18:32, il y a 2 jours 10 heures Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Publié le 02/04/2026 à 15:00, il y a 2 jours 14 heures Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Publié le 02/04/2026 à 14:40, il y a 2 jours 14 heures Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Publié le 02/04/2026 à 14:30, il y a 2 jours 14 heures Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Publié le 04/04/2026 à 10:07, il y a 18 heures 54 minutes Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Publié le 04/04/2026 à 02:05, il y a 1 jour 2 heures Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Publié le 03/04/2026 à 18:00, il y a 1 jour 11 heures IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Publié le 03/04/2026 à 18:00, il y a 1 jour 11 heures IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Publié le 03/04/2026 à 17:45, il y a 1 jour 11 heures Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems